Microbiota Metabolite Profiles and Dietary Intake in Older Individuals with Insomnia of Short vs. Normal Sleep Duration

Carmel Even,Faiga Magzal,Tamar Shochat,Iris Haimov,Maayan Agmon,Snait Tamir
DOI: https://doi.org/10.3390/biom14040419
IF: 6.064
2024-03-31
Biomolecules
Abstract:Recent evidence suggests that the gut microbiota plays a role in insomnia pathogenesis. This study compared the dietary habits and microbiota metabolites of older adults with insomnia of short vs. normal sleep duration (ISSD and INSD, respectively). Data collection included sleep assessment through actigraphy, dietary analysis using the Food Frequency Questionnaire, and metabolomic profiling of stool samples. The results show that ISSD individuals had higher body mass index and a greater prevalence of hypertension. Significant dietary differences were observed, with the normal sleep group consuming more kilocalories per day and specific aromatic amino acids (AAAs) phenylalanine and tyrosine and branch-chain amino acid (BCAA) valine per protein content than the short sleep group. Moreover, metabolomic analysis identified elevated levels of the eight microbiota metabolites, benzophenone, pyrogallol, 5-aminopental, butyl acrylate, kojic acid, deoxycholic acid (DCA), trans-anethole, and 5-carboxyvanillic acid, in the short compared to the normal sleep group. The study contributes to the understanding of the potential role of dietary and microbial factors in insomnia, particularly in the context of sleep duration, and opens avenues for targeted dietary interventions and gut microbiota modulation as potential therapeutic approaches for treating insomnia.
biochemistry & molecular biology
What problem does this paper attempt to address?
The paper attempts to address the differences in dietary habits and microbiome metabolites between two phenotypes of insomnia in the elderly: short sleep duration and normal sleep duration. The main objective of the study is to explore how these differences affect insomnia and to provide potential pathways for further treatment of insomnia through dietary interventions and gut microbiome regulation. The study found significant differences between individuals with insomnia and short sleep duration (ISSD) and those with insomnia and normal sleep duration (INSD) in terms of body mass index (BMI), blood pressure, amino acid intake, and gut microbiome metabolites. Specifically: 1. **Amino Acid Intake**: ISSD individuals had lower intake of aromatic amino acids (such as phenylalanine and tyrosine) and branched-chain amino acids (such as valine), which are believed to be related to sleep regulation. 2. **Microbiome Metabolites**: In ISSD individuals, levels of some metabolites associated with microbiome dysbiosis (such as deoxycholic acid) were elevated. These findings support the potential role of diet and microbiome metabolites in insomnia and suggest that insomnia could be treated by adjusting diet and improving the gut microbiome.